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Mitochondria, which is one of eukaryotic organelles, plays an important role in the 
production of ATP to supply energy required for various activities of cells. Cells of the heart 
and brown adipose tissue (BAT) contain many mitochondria and consume large amounts of 
energy. In vivo measurement of the mitochondrial activity could be valuable for diagnosis of 
diseases caused by mitochondrial dysfunction. 18F-FBnTP is a fluorine-18 labeled 
triarylphosphonium (TAP) compound which accumulates in mitochondria depending on 
mitochondria membrane potential (MMP) (1). Although 18F-FBnTP has been often used for 
imaging and assessing mitochondrial function of the heart and BAT in basic research, the 
complicated reaction procedures and sever reaction conditions for the radiosynthesis have 
hampered the clinical application of the tracer. To overcome this difficulty, we have been tried 
to develop new 18F-labeled TAP derivatives (2). In this study, we have established a novel 
convenient method for synthesizing 18F-labeled TAP compounds. 
 
Methods 
As the new radiosynthesis strategy different from conventional one, we devised a 
method to synthesize a 18F-labeled phosphonium compound by synthesizing a 18F-labeled 
triarylphosphine as an intermediate and then reacting it with an appropriate electrophile. 
Firstly, the reaction conditions of solvent and temperature for preparation of the phosphonium 
scaffold from 18F-labeled phosphine intermediate and benzyl bromide (electrophile) were 
examined. Then, we tested several derivatives of benzyl bromide for synthesizing the 18F-
labeled phosphonium derivatives (18F-TP-001~006) under the optimized reaction conditions. 




imaging tracer. Each tracer was injected into the mouse or rat tail vein and evaluated the tissue 
uptake rate of the tracer by biodistribution study and small animal PET imaging. Cellular 
uptake mechanism of the tracer was also examined by using a JC-10 probe for MMP 
measurement. 
 
Results and Discussion 
A 18F-labeled triarylphosphine was prepared from the corresponding tosylate 
precursor by conventional radiofluorination method using 18F-KF/K222, and then reacted 
with benzyl bromide. As the results of the examination of the second reaction conditions, the 
solvent, temperature, and time were optimized as acetonitrile, 100ºC, and 10 min, respectively. 
Under the conditions, 18F-TP-001 was radiosynthesized in good radiochemical yields of 
43±18% (Fig. 1). The other 18F-TP derivatives were also prepared in moderate-to-good 
radiochemical yields under the same conditions. This method is a simple one-pot procedure 
and requires no corrosive reagents and sever reaction conditions, suggesting the feasibility of 
automated radiosynthesis of 18F-TP. 
Biodistribution study revealed that most of the derivatives showed high heart uptakes 
at 60 min post-injection. Especially, 18F-TP-003 indicated higher accumulation in 
myocardium compared to other compounds with a large heart-to-liver uptake ratio (9.2). 
Cellular accumulation rate of 18F-TP-003 was correlated well with a JC-10 uptake among 
three different cell lines, indicating that cellular accumulation of 18F-TP-003 depends on 
MMP. Rat heart was clearly visualized by PET with 18F-TP-003 (Fig. 2).   
 
Conclusion 
We developed a novel method for a synthesis of 18F-labeled TP derivative by one-pot 
procedure. This method would increase the flexibility in drug design of 18F-TP and be useful 
in the study on structure-activity relationship. 18F-TP-003, one of the 18F-TP derivatives, 
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